Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies

por Huang, Bo-Cheng, Lu, Yun-Chi, Liao, Jun-Min, Liu, Hui-Ju, Hong, Shih-Ting, Hsieh, Yuan-Chin, Chuang, Chih-Hung, Chen, Huei-Jen, Liao, Tzu-Yi, Ho, Kai-Wen, Wang, Yeng-Tseng, Cheng, Tian-Lu
Publicado 2021

Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies

por Huang, Bo-Cheng, Lu, Yun-Chi, Liao, Jun-Min, Liu, Hui-Ju, Hong, Shih-Ting, Hsieh, Yuan-Chin, Chuang, Chih-Hung, Chen, Huei-Jen, Liao, Tzu-Yi, Ho, Kai-Wen, Wang, Yeng-Tseng, Cheng, Tian-Lu
Publicado 2021

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy

por Lin, Wen-Wei, Cheng, Yi-An, Li, Chia-Ching, Ho, Kai-Wen, Chen, Huei-Jen, Chen, I.-J.u, Huang, Bo-Cheng, Liu, Hui-Ju, Lu, Yun-Chi, Cheng, Chiu-Min, Huang, Ming-Yii, Lai, Hung-Wen, Cheng, Tian-Lu
Publicado 2021

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy

por Lin, Wen-Wei, Lu, Yun-Chi, Huang, Bo-Cheng, Chuang, Chih-Hung, Cheng, Yi-An, Chen, I.-Ju, Liu, Hui-Ju, Ho, Kai-Wen, Liao, Tzu-Yi, Liu, En-Shuo, Wu, Ting-Yi, Chang, Long-Sen, Hong, Shih-Ting, Cheng, Tian-Lu
Publicado 2021

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor acti...

por Ho, Kai-Wen, Chen, I.-J.u, Cheng, Yi-An, Liao, Tzu-Yi, Liu, En-Shuo, Chen, Huei-Jen, Lu, Yun-Chi, Su, Yu-Cheng, Roffler, Steve R., Huang, Bo-Cheng, Liu, Hui-Ju, Huang, Ming-Yii, Chen, Chiao-Yun, Cheng, Tian-Lu
Publicado 2021

Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice

por Lin, Wen-Wei, Ho, Kai-Wen, Su, Hsiang-Han, Fang, Tien-Fang, Tzou, Shey-Cherng, Chen, I-Ju, Lu, Yun-Chi, Chang, Mu-Shen, Tsai, Yun-Chen, Liu, En-Shuo, Su, Yu-Cheng, Wang, Yen-Tseng, Cheng, Tian-Lu, Huang, Hsin-Kai
Publicado 2021

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies

por Hsieh, Yuan-Chin, Liao, Jun-min, Chuang, Kuo-Hsiang, Ho, Kai-Wen, Hong, Shih-Ting, Liu, Hui-Ju, Huang, Bo-Cheng, Chen, I-Ju, Liu, Yen-Ling, Wang, Jaw-Yuan, Tsai, Hsiang-Lin, Su, Yu-Cheng, Wang, Yen-Tseng, Cheng, Tian-Lu
Publicado 2022